0001209191-23-059337.txt : 20231220 0001209191-23-059337.hdr.sgml : 20231220 20231220162201 ACCESSION NUMBER: 0001209191-23-059337 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231113 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: 22NW Fund, LP CENTRAL INDEX KEY: 0001640809 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 231501543 BUSINESS ADDRESS: STREET 1: 1455 NW LEARY WAY STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98107 BUSINESS PHONE: 206-227-3078 MAIL ADDRESS: STREET 1: 1455 NW LEARY WAY STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: 22NW, LP CENTRAL INDEX KEY: 0001694297 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 231501544 BUSINESS ADDRESS: STREET 1: 590 1ST AVE S, UNIT C1 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-437-9174 MAIL ADDRESS: STREET 1: 590 1ST AVE S, UNIT C1 CITY: SEATTLE STATE: WA ZIP: 98104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: English Aron R. CENTRAL INDEX KEY: 0001770436 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 231501545 MAIL ADDRESS: STREET 1: 1455 NW LEARY WAY, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-13 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001770436 English Aron R. C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 1 0 1 0 0001694297 22NW, LP 590 1ST AVE S UNIT C-1 SEATTLE WA 98104 0 0 1 0 0001640809 22NW Fund, LP 590 1ST AVE S UNIT C-1 SEATTLE WA 98104 0 0 1 0 0 Common Stock 2023-11-13 4 A 0 300000 0.00 A 300000 I 22NW, LP Common Stock 2023-12-18 4 G 0 300000 0.00 D 0 I 22NW, LP Common Stock 2023-12-18 4 G 0 300000 0.00 A 5366290 I 22NW Fund, LP Common Stock 4654528 I Pharma Investors, LLC The shares were issued to 22NW, LP as partial consideration for entering into a loan and security agreement with the Issuer. This Form 4 is filed jointly by Aron R. English, 22NW, LP and 22NW Fund, LP (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. Securities owned directly by 22NW, LP. Mr. English, as the Manager of 22NW, LP may be deemed to beneficially own the securities owned directly by 22NW, LP. Securities owned directly by 22NW Fund, LP. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP. Securities owned directly by Pharma Investors, LLC. Mr. English, as the owner of Pharma Investors, LLC, may be deemed to beneficially own the securities owned directly by Pharma Investors, LLC. /s/ Aron R. English 2023-12-20 22NW, LP; By: 22NW GP, Inc.; By: /s/ Aron R. English, President and Sole Shareholder 2023-12-20 22NW Fund, L.P.; By: 22 NW Fund GP, LLC; By /s/ Aron R. English 2023-12-20